Kobayashi Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-	13,914	27,559	27,950	27,636
Depreciation & Amortization	-	8,022	6,057	5,358	4,835
Loss (Gain) From Sale of Assets	-	50	118	121	378
Loss (Gain) From Sale of Investments	-	-635	-436	89	-84
Other Operating Activities	-	-7,493	-8,359	-8,007	-8,396
Change in Accounts Receivable	-	4,780	-3,781	8,296	-1,523
Change in Inventory	-	-1,144	-3,175	-1,977	-462
Change in Accounts Payable	-	-9,447	361	515	-158
Change in Other Net Operating Assets	-	3,199	16	-431	193
Operating Cash Flow	-	11,246	18,360	31,914	22,419
Operating Cash Flow Growth	-	-38.75%	-42.47%	42.35%	-6.53%
Capital Expenditures	-	-26,056	-12,756	-14,747	-3,663
Sale of Property, Plant & Equipment	-	22	5	3	10
Cash Acquisitions	-	-	-11,176	-	-
Divestitures	-	-	-	-	200
Sale (Purchase) of Intangibles	-	-573	-813	-1,482	-522
Investment in Securities	-	8,053	5,395	2,168	12,095
Other Investing Activities	-	139	-231	-254	-129
Investing Cash Flow	-	-18,415	-19,576	-14,312	7,991
Short-Term Debt Repaid	-	-	-	-1	-12
Total Debt Repaid	-	-	-	-1	-12
Net Debt Issued (Repaid)	-	-	-	-1	-12
Repurchase of Common Stock	-	-	-12,000	-14,056	-3,943
Common Dividends Paid	-	-7,505	-7,223	-6,509	-6,251
Other Financing Activities	-	-263	-240	-193	-171
Financing Cash Flow	-	-7,768	-19,463	-20,759	-10,377
Foreign Exchange Rate Adjustments	-	1,220	890	673	797
Miscellaneous Cash Flow Adjustments	-	-	-	-22	-
Net Cash Flow	-	-13,717	-19,789	-2,506	20,830
Free Cash Flow	-	-14,810	5,604	17,167	18,756
Free Cash Flow Growth	-	-	-67.36%	-8.47%	-7.11%
Free Cash Flow Margin	-	-8.94%	3.23%	10.33%	12.08%
Free Cash Flow Per Share	-	-199.22	73.89	222.57	240.08
Cash Interest Paid	-	34	22	18	17
Cash Income Tax Paid	-	7,471	8,358	8,003	8,464
Levered Free Cash Flow	-	-13,061	2,535	11,183	14,511
Unlevered Free Cash Flow	-	-13,043	2,553	11,194	14,522
Change in Working Capital	-	-2,612	-6,579	6,403	-1,950

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.